Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
Gastrointestinal symptoms in Chinese patients with type 2 diabetes mellitus
nsMRA, nonsteroidal mineralocorticoid receptor antagonist
SASP leads to long-lasting inflammation and tissue damage
Clinical trials show that approximately 50% of weight loss is regained within one year of stopping GLP-1 therapy, and many patients return to baseline weight within 23 years
Weeks 5 to 8 at therapeutic doses of 1.0 to 1.7 mg
US$ 24.70
US$ 23.40
US$ 26.17
US$ 22.69
US$ 24.22
US$ 26.32
